Hosted on MSN2d
Moderna’s mRESVIA vaccine gains Health Canada approval
Moderna has received Health Canada's approval for its respiratory syncytial virus messenger ribonucleic acid (mRNA) ...
Canada approves Moderna's RSV vaccine for adults aged 60 and older
Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...
Do COVID-19 boosters still make sense? What to know about the latest vaccine rollout
Canada’s panel of vaccine advisers has strongly recommended the new vaccines targeting the KP.2 strain, part of the Omicron lineage, for the previously vaccinated or unvaccinated at increased risk ...
The Canadian Press on MSN1d
Avian flu in humans: Pink eye a symptom, unclear if flu vaccine will offer protection
Human-to-human transmission is very rare, but as cases among animals rise, many experts are worried the virus could develop ...
Eagle-Tribune5d
Moderna Receives Health Canada Approval for RSV Vaccine for Adults Aged 60 Years and Older
mRESVIA is Moderna's second approved product in Canada, the first mRNA vaccine against RSV, and the only one in single-dose pre-filled syringes Canada is the fourth jurisdiction to approve ...
Idaho health agency halts COVID vaccine program, joining backlash
Southwest District Health ended its COVID-19 vaccination program. Others in Texas, Florida and Michigan also pushed back ...
Vaccine doses allocated for 9 African countries hardest hit by mpox
The global health agency said on Wednesday the newly allocated vaccines will go to the Central African Republic, Ivory Coast, the Democratic Republic of Congo, Kenya, Liberia, Nigeria, Rwanda, South A ...
GlobalData on MSN7d
GSK’s RSV vaccine approved in Canada for adults aged 50 to 59
GlaxoSmithKline (GSK) has received approval for its vaccine, AREXVY, in Canada to prevent lower respiratory tract disease ...